Total Payments
$344.48
2024 Payments
$47.00
Companies
7
Transactions
24
Medicare Patients
8,571
Medicare Billing
$679,164
Payment Breakdown by Category
Food & Beverage$327.38 (95.0%)
Education$17.10 (5.0%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $327.38 | 23 | 95.0% |
| Education | $17.10 | 1 | 5.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $174.34 | 15 | $0 (2024) |
| Taro Pharmaceuticals USA, Inc. | $45.86 | 3 | $0 (2018) |
| ABBVIE INC. | $42.70 | 2 | $0 (2022) |
| Krystal Biotech Inc | $26.00 | 1 | $0 (2024) |
| GENZYME CORPORATION | $24.91 | 1 | $0 (2020) |
| Lilly USA, LLC | $17.90 | 1 | $0 (2021) |
| Galderma Laboratories, L.P. | $12.77 | 1 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $47.00 | 2 | Krystal Biotech Inc ($26.00) |
| 2023 | $35.27 | 2 | Novartis Pharmaceuticals Corporation ($35.27) |
| 2022 | $173.54 | 15 | Novartis Pharmaceuticals Corporation ($118.07) |
| 2021 | $17.90 | 1 | Lilly USA, LLC ($17.90) |
| 2020 | $24.91 | 1 | GENZYME CORPORATION ($24.91) |
| 2018 | $45.86 | 3 | Taro Pharmaceuticals USA, Inc. ($45.86) |
All Payment Transactions
24 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/23/2024 | Krystal Biotech Inc | VYJUVEK (Drug) | Food and Beverage | In-kind items and services | $26.00 | General |
| Category: DERMATOLOGY | ||||||
| 08/15/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $21.00 | General |
| Category: Dermatology | ||||||
| 07/31/2023 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $13.31 | General |
| Category: Dermatology | ||||||
| 05/15/2023 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $21.96 | General |
| Category: Dermatology | ||||||
| 12/21/2022 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $18.84 | General |
| Category: IMMUNOLOGY | ||||||
| 11/29/2022 | Novartis Pharmaceuticals Corporation | COSENTYX (Biological) | Food and Beverage | In-kind items and services | $11.15 | General |
| Category: IMMUNOLOGY | ||||||
| 11/03/2022 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $23.86 | General |
| Category: IMMUNOLOGY | ||||||
| 10/04/2022 | Novartis Pharmaceuticals Corporation | COSENTYX (Biological) | Food and Beverage | In-kind items and services | $6.50 | General |
| Category: IMMUNOLOGY | ||||||
| 09/21/2022 | Galderma Laboratories, L.P. | EPSOLAY (Drug), TRI-LUMA, TWYNEO | Food and Beverage | In-kind items and services | $12.77 | General |
| Category: ROSACEA | ||||||
| 09/02/2022 | Novartis Pharmaceuticals Corporation | COSENTYX (Biological) | Food and Beverage | In-kind items and services | $11.84 | General |
| Category: IMMUNOLOGY | ||||||
| 08/23/2022 | Novartis Pharmaceuticals Corporation | COSENTYX (Biological) | Food and Beverage | In-kind items and services | $5.69 | General |
| Category: IMMUNOLOGY | ||||||
| 08/03/2022 | Novartis Pharmaceuticals Corporation | COSENTYX (Biological) | Food and Beverage | In-kind items and services | $9.59 | General |
| Category: IMMUNOLOGY | ||||||
| 07/08/2022 | Novartis Pharmaceuticals Corporation | COSENTYX (Biological) | Food and Beverage | In-kind items and services | $4.89 | General |
| Category: IMMUNOLOGY | ||||||
| 05/04/2022 | Novartis Pharmaceuticals Corporation | COSENTYX (Biological) | Food and Beverage | In-kind items and services | $10.84 | General |
| Category: IMMUNOLOGY | ||||||
| 04/27/2022 | Novartis Pharmaceuticals Corporation | COSENTYX (Biological) | Food and Beverage | In-kind items and services | $18.56 | General |
| Category: IMMUNOLOGY | ||||||
| 02/22/2022 | Novartis Pharmaceuticals Corporation | COSENTYX (Biological) | Food and Beverage | In-kind items and services | $6.85 | General |
| Category: IMMUNOLOGY | ||||||
| 02/01/2022 | Novartis Pharmaceuticals Corporation | COSENTYX (Biological) | Food and Beverage | In-kind items and services | $10.44 | General |
| Category: IMMUNOLOGY | ||||||
| 01/26/2022 | Novartis Pharmaceuticals Corporation | COSENTYX (Biological) | Food and Beverage | In-kind items and services | $10.98 | General |
| Category: IMMUNOLOGY | ||||||
| 01/05/2022 | Novartis Pharmaceuticals Corporation | COSENTYX (Biological) | Food and Beverage | In-kind items and services | $10.74 | General |
| Category: IMMUNOLOGY | ||||||
| 04/29/2021 | Lilly USA, LLC | TALTZ (Drug) | Food and Beverage | In-kind items and services | $17.90 | General |
| Category: Immunology | ||||||
| 11/17/2020 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $24.91 | General |
| Category: Immunology | ||||||
| 06/20/2018 | Taro Pharmaceuticals USA, Inc. | ULTRAVATE (halobetasol propionate) lotion (Drug) | Food and Beverage | In-kind items and services | $13.88 | General |
| Category: Dermatology | ||||||
| 02/20/2018 | Taro Pharmaceuticals USA, Inc. | TOPICORT (desoximetasone) Topical Spray, 0.25% (Drug) | Food and Beverage | In-kind items and services | $14.88 | General |
| Category: Dermatology | ||||||
| 01/22/2018 | Taro Pharmaceuticals USA, Inc. | HALOG OINTMENT (Halcinonide Ointment, USP) 0.1% (Drug), HALOG (Halcinonide Cream, USP) 0.1%, ULTRAVATE (halobetasol propionate) lotion | Education | In-kind items and services | $17.10 | General |
| Category: Dermatology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 14 | 2,197 | 3,168 | $471,360 | $172,602 |
| 2022 | 13 | 2,140 | 3,242 | $459,612 | $173,908 |
| 2021 | 14 | 2,119 | 3,274 | $422,802 | $179,913 |
| 2020 | 15 | 2,115 | 3,102 | $390,713 | $152,740 |
Total Patients
8,571
Total Services
12,786
Medicare Billing
$679,164
Procedure Codes
56
All Medicare Procedures & Services
56 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 783 | 1,160 | $192,400 | $67,363 | 35.0% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 387 | 472 | $81,005 | $32,530 | 40.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 165 | 195 | $44,340 | $17,758 | 40.0% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 166 | 191 | $34,380 | $15,414 | 44.8% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 240 | 293 | $36,625 | $11,858 | 32.4% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 111 | 165 | $13,800 | $6,474 | 46.9% |
| 12032 | Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | Office | 2023 | 26 | 26 | $13,390 | $6,249 | 46.7% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 39 | 39 | $7,670 | $2,946 | 38.4% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 62 | 69 | $8,460 | $2,514 | 29.7% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 158 | 497 | $19,880 | $2,314 | 11.6% |
| 12031 | Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.5 cm or less | Office | 2023 | 11 | 11 | $4,165 | $2,262 | 54.3% |
| 17262 | Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | Office | 2023 | 15 | 16 | $4,720 | $2,258 | 47.8% |
| 11602 | Removal of cancer skin growth of body, arms, or legs, 1.1-2.0 cm | Office | 2023 | 19 | 19 | $8,645 | $1,995 | 23.1% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2023 | 15 | 15 | $1,880 | $669.51 | 35.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 793 | 1,234 | $195,480 | $71,743 | 36.7% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 372 | 467 | $77,055 | $33,453 | 43.4% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2022 | 181 | 214 | $38,520 | $16,593 | 43.1% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 242 | 306 | $38,250 | $12,961 | 33.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 81 | 112 | $24,560 | $10,504 | 42.8% |
| 12032 | Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | Office | 2022 | 25 | 26 | $13,390 | $6,557 | 49.0% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2022 | 110 | 160 | $12,800 | $6,404 | 50.0% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 78 | 105 | $12,600 | $4,322 | 34.3% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 55 | 55 | $10,450 | $3,743 | 35.8% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2022 | 145 | 503 | $20,120 | $2,605 | 12.9% |
| 17262 | Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | Office | 2022 | 18 | 20 | $5,892 | $2,574 | 43.7% |
About Dr. Adam Czelusta, MD
Dr. Adam Czelusta, MD is a Dermatology healthcare provider based in Katy, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/02/2005. The National Provider Identifier (NPI) number assigned to this provider is 1033110929.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Adam Czelusta, MD has received a total of $344.48 in payments from pharmaceutical and medical device companies, with $47.00 received in 2024. These payments were reported across 24 transactions from 7 companies. The most common payment nature is "Food and Beverage" ($327.38).
As a Medicare-enrolled provider, Czelusta has provided services to 8,571 Medicare beneficiaries, totaling 12,786 services with total Medicare billing of $679,164. Data is available for 4 years (2020–2023), covering 56 distinct procedure/service records.
Ad
Practice Information
- Specialty Dermatology
- Location Katy, TX
- Active Since 08/02/2005
- Last Updated 09/21/2010
- Taxonomy Code 207N00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1033110929
Products in Payments
- COSENTYX (Biological) $118.07
- COSENTYX (Drug) $56.27
- RINVOQ (Biological) $42.70
- VYJUVEK (Drug) $26.00
- DUPIXENT (Biological) $24.91
- TALTZ (Drug) $17.90
- HALOG OINTMENT (Halcinonide Ointment, USP) 0.1% (Drug) $17.10
- TOPICORT (desoximetasone) Topical Spray, 0.25% (Drug) $14.88
- ULTRAVATE (halobetasol propionate) lotion (Drug) $13.88
- EPSOLAY (Drug) $12.77
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Dermatology Doctors in Katy
Connie Wang, M.d, M.D
Dermatology — Payments: $55,293
Dermatology $55,293
Filiberto Cedeno Laurent, Md, Phd, MD, PHD
Dermatology — Payments: $23,083
Dermatology $23,083
Danielle Applebaum
Dermatology — Payments: $16,965
Dermatology $16,965
Uyen Ngoc Mui, Md, MD
Dermatology — Payments: $10,381
Dermatology $10,381
Rachel Schmidtberger, M.d, M.D
Dermatology — Payments: $9,055
Dermatology $9,055
Dr. Sana Zahiruddin, M.d, M.D
Dermatology — Payments: $8,857
Dermatology $8,857